Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse events.

Front Oncol · 2023 · PMC10126279 · PMID 37114123

Europe PMC DOI

hedged sentence

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

a decreasing trendP =0.078so close (0.05 < p ≤ 0.1)

Significant changes in butyrate-producing bacteria were also presented in the SR cohort ( P =0.043) with a decreasing trend upon secondary resistance occurrence ( P =0.078).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.